Literature DB >> 18598732

Vaccine immunogenetics: bedside to bench to population.

Gregory A Poland1, Inna G Ovsyannikova, Robert M Jacobson.   

Abstract

The immunogenetic basis for variations in immune response to vaccines in humans remains largely unknown. Many factors can contribute to the heterogeneity of vaccine-induced immune responses, including polymorphisms of immune response genes. It is important to identify those genes involved directly or indirectly in the generation of the immune response to vaccines. Our previous work with measles reveals the impact of immune response gene polymorphisms on measles vaccine-induced humoral and cellular immune responses. We demonstrate associations between genetic variations (single nucleotide polymorphisms, SNPs) in HLA class I and class II genes, cytokine, cell surface receptor, and toll-like receptor genes and variations in immune responses to measles vaccine. Such information may provide further understanding of genetic restrictions that influence the generation of protective immune responses to vaccines, and eventually the development of new vaccines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598732      PMCID: PMC2614670          DOI: 10.1016/j.vaccine.2008.06.057

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  54 in total

1.  Ten great public health achievements--United States, 1900-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-04-02       Impact factor: 17.586

2.  HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Robert A Vierkant; V Shane Pankratz; Steven J Jacobsen; Gregory A Poland
Journal:  Immunogenetics       Date:  2005-01-27       Impact factor: 2.846

Review 3.  Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response.

Authors:  G A Poland
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 4.  The genetic basis for variation in antibody response to vaccines.

Authors:  G A Poland; R M Jacobson
Journal:  Curr Opin Pediatr       Date:  1998-04       Impact factor: 2.856

5.  Therapeutics and toxicology.

Authors:  S P Spielberg
Journal:  Curr Opin Pediatr       Date:  1998-04       Impact factor: 2.856

Review 6.  Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease.

Authors:  Nicolas W J Schröder; Ralf R Schumann
Journal:  Lancet Infect Dis       Date:  2005-03       Impact factor: 25.071

7.  Measles reimmunization in children seronegative after initial immunization.

Authors:  G A Poland; R M Jacobson; A M Thampy; S A Colbourne; P C Wollan; J J Lipsky; S J Jacobsen
Journal:  JAMA       Date:  1997-04-09       Impact factor: 56.272

8.  In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene.

Authors:  V Pravica; A Asderakis; C Perrey; A Hajeer; P J Sinnott; I V Hutchinson
Journal:  Eur J Immunogenet       Date:  1999-02

Review 9.  Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons.

Authors:  G A Poland; R M Jacobson
Journal:  Arch Intern Med       Date:  1994-08-22

Review 10.  The major histocompatibility complex: the value of extended haplotypes in the analysis of associated immune diseases and disorders.

Authors:  M S Kruskall
Journal:  Yale J Biol Med       Date:  1990 Sep-Oct
View more
  40 in total

1.  Genetic determinants of immune-response to a polysaccharide vaccine for typhoid.

Authors:  Partha P Majumder; Herman F Staats; Neeta Sarkar-Roy; Binuja Varma; Trina Ghosh; Sujit Maiti; K Narayanasamy; Carol C Whisnant; James L Stephenson; Diane K Wagener
Journal:  Hugo J       Date:  2010-03-11

2.  The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Hum Genet       Date:  2011-03-19       Impact factor: 4.132

3.  Consistency of HLA associations between two independent measles vaccine cohorts: a replication study.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-25       Impact factor: 3.641

Review 4.  Vaccinomics: current findings, challenges and novel approaches for vaccine development.

Authors:  Inna G Ovsyannikova; Gregory A Poland
Journal:  AAPS J       Date:  2011-06-14       Impact factor: 4.009

Review 5.  Searching for the human genetic factors standing in the way of universally effective vaccines.

Authors:  Alexander J Mentzer; Daniel O'Connor; Andrew J Pollard; Adrian V S Hill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

6.  Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Megan M O'Byrne; Robert M Jacobson; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-20       Impact factor: 3.641

Review 7.  The role of Toll-like receptor 4 polymorphisms in vaccine immune response.

Authors:  P Pellegrino; F S Falvella; S Cheli; C Perrotta; E Clementi; S Radice
Journal:  Pharmacogenomics J       Date:  2015-03-31       Impact factor: 3.550

Review 8.  The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines.

Authors:  Abdulmohammad Pezeshki; Inna G Ovsyannikova; Brett A McKinney; Gregory A Poland; Richard B Kennedy
Journal:  Expert Rev Vaccines       Date:  2019-02-11       Impact factor: 5.217

9.  Genomic correlates of variability in immune response to an oral cholera vaccine.

Authors:  Partha P Majumder; Neeta Sarkar-Roy; Herman Staats; T Ramamurthy; Sujit Maiti; Goutam Chowdhury; Carol C Whisnant; K Narayanasamy; Diane K Wagener
Journal:  Eur J Hum Genet       Date:  2012-12-19       Impact factor: 4.246

Review 10.  Next-generation sequencing: a transformative tool for vaccinology.

Authors:  Neelam Dhiman; David I Smith; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2009-08       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.